The stock price of Zydus Lifesciences surged over 5 per cent in the Tuesday trading session after the drugmaker’s wholly owned subsidiary, Sentynl Therapeutics, received U.S. Food and Drug ...

Zydus Pharmaceuticals USA Inc President & CEO Punit Patel said the relationship is a strong validation of Zydus' strategic investments in the new drug applications portfolio.

According to a Reuters article, pharma companies launched new US drugs at prices 35% higher in 2023 compared to those ...

and ZituvimetTM XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) tablets to its template formulary," the filing read. The Zituvio range of products contains active ingredients sitagliptin, a ...

On Tuesday, 2624 stocks advanced, 1355 declined and 107 remained unchanged, with an advance decline ratio of 1.93x on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader ...

Indian equity markets closed lower past week, with the NIFTY down by 573 points or 2.39% and the Sensex down by 2.33%. But ...

Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...

Metformin, a widely prescribed medication for type 2 diabetes, may help protect individuals from the 2 most common types of ...

A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...